(Q24246213)

https://api.crossref.org/works/10.1002%2F14651858.CD002978.PUB2

Combined versus sequential hormonal replacement therapy: a double-blind, placebo-controlled study on quality of life-related outcome measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002978.PUB2

Effects of "natural oestrogen" replacement therapy on menopausal symptoms and blood clotting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002978.PUB2

Hormone therapy and affect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002978.PUB2

Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002978.PUB2

Effects of two years' estrogen-gestagen replacement on climacteric symptoms and gonadotropins in the early postmenopausal period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002978.PUB2

Dose-response and withdrawal effects on climacteric symptoms after hormonal replacement therapy. A placebo-controlled therapeutic trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002978.PUB2

Uncoupling of bone formation and resorption by combined oestrogen and progestagen therapy in postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002978.PUB2

Progestogens: therapeutic and adverse effects in early post-menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002978.PUB2

A randomised, double-blind, cross-over study into the effect of sequential mestranol and norethisterone on climacteric symptoms and biochemical parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002978.PUB2

Baseline characteristics of the PEPI participants. Postmenopausal Estrogen/Progestin Interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002978.PUB2

The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002978.PUB2

Treatment of climacteric complaints with Org OD 14: a comparative study with oestradiol valerate and placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002978.PUB2

The effect of estrogen therapy on somatic and psychical symptoms in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002978.PUB2

Comparison of continuous and sequential oestrogen-progestogen treatment in women with climacteric symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002978.PUB2

Individual differences in changes in mood and platelet monoamine oxidase (MAO) activity during hormonal replacement therapy in menopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002978.PUB2

Effects of Estrogen, Androgen, and Progestin on Sexual Psychophysiology and Behavior in Postmenopausal Women*

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002978.PUB2

Menopausal symptom control and side-effects on continuous estrone sulfate and three doses of medroxyprogesterone acetate. Ogen/Provera Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002978.PUB2

Estrogen Replacement Therapy II: A Prospective Study in the Relationship to Carcinoma and Cardiovascular and Metabolic Problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002978.PUB2

Transdermal oestrogen for postmenopausal women: a double blind crossover comparative study with ethinyl oestradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002978.PUB2

When does estrogen replacement therapy improve sleep quality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002978.PUB2

The effect of short-term estrogen replacement therapy on cognition: a randomized, double-blind, cross-over trial in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002978.PUB2

Relationship among Estrogen-induced Psychophysiological Changes in Hypogonadal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002978.PUB2

Effects of Estrogens on Sleep and Psychological State of Hypogonadal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002978.PUB2

Low-dose esterified estrogens (0.3 mg/day): long-term and short-term effects on menopausal symptoms and quality of life in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002978.PUB2

The pharmacokinetics of ethynyl estrogens. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002978.PUB2

Differential diagnosis of hot flashes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002978.PUB2

Explaining heterogeneity in meta-analysis: a comparison of methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002978.PUB2

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002978.PUB2

Combining summaries of binary outcomes with those of continuous outcomes in a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002978.PUB2

Efficacy and safety of Menorest (50 mikrog/day) compared to Premarin 0.625 mg in the treatment of menopausal symptoms and the prevention of bone loss, in menopausal women. A single-center, comparative, randomized, double-blind, double-dummy study

21 January 2018

1 reference

12 December 2020

Nylestriol replacement therapy in postmenopausal women. A three-year prospective study.

1 reference

12 December 2020

A population based survey of women's experience of the menopause.

1 reference

12 December 2020

A randomized double-blind cross-over trial into the effect of norethisterone on climacteric symptoms and biochemical profiles.

1 reference

12 December 2020

Hormone replacement therapy in perimenopausal women with a triphasic contraceptive compound: a three-year prospective study.

1 reference

12 December 2020

Graded sequential therapy in the menopause: a double-blind study

1 reference

12 December 2020

The Effect of Castration and Peroral Estrogen Therapy on Some Psychological Functions

1 reference

12 December 2020

Cyproterone acetate, an alternative progestogen in postmenopausal hormone replacement therapy? Effects on serum lipids and lipoproteins

1 reference

12 December 2020

Is oestrogen therapy effective in the treatment of menopausal depression?

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled, cross-over trial to assess the side effects of medroxyprogesterone acetate in hormone replacement therapy

1 reference

12 December 2020

A two-year double-blind controlled study of the clinical effect of combined and sequential postmenopausal replacement therapy and steroid metabolism during treatment

1 reference

12 December 2020

Core body temperature and circadian rhythm of hot flashes in menopausal women

1 reference

12 December 2020

Benefits and risks of different hormonal replacement therapies in post-menopausal women

1 reference

12 December 2020

The climacteric syndrome: an estrogen replacement dilemma

1 reference

12 December 2020

Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial

1 reference

12 December 2020

Menopausal hot flushes: a double blind comparison of placebo, ethinyl oestradiol and norgestrel

1 reference

12 December 2020

Effect of a unique constant-estrogen, pulsed-progestin hormone replacement therapy containing 17beta-estradiol and norgestimate on endometrial histology

1 reference

12 December 2020

Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding

1 reference

12 December 2020

A randomized comparison of continuous combined transdermal delivery of estradiol-norethindrone acetate and estradiol alone for menopause. CombiPatch Study Group

1 reference

12 December 2020

Postmenopausal women without previous or current vasomotor symptoms do not flush after abruptly abandoning estrogen replacement therapy

1 reference

12 December 2020

A double-blind comparative study of Estraderm and Premarin in the amelioration of postmenopausal symptoms

1 reference

12 December 2020

Conjugated equine oestrogen versus placebo in the management of menopausal symptoms

1 reference

12 December 2020

A placebo-controlled trial of ethinyl oestradiol and norethisterone in climacteric women

1 reference

12 December 2020

Prevention of early postmenopausal bone loss using low doses of conjugated estrogens and the non-hormonal, bone-active drug ipriflavone

1 reference

12 December 2020

The influence of oestrogens on the wellbeing and mental performance in climacteric and postmenopausal women

1 reference

12 December 2020

Oestriol succinate in the treatment of climacteric women (a double-blind trial)

1 reference

12 December 2020

The mental tonic effect of oestrogens administered to oöphorectomized females.

1 reference

12 December 2020

The use of cyclofenil in menopausal women

1 reference

12 December 2020

A double-blind cross-over study of piperazine oestrone sulphate and placebo with coagulation studies

1 reference

12 December 2020

Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss

1 reference

12 December 2020

Plasma levels of ethinyl oestradiol and norgestrel during hormone replacement therapy

1 reference

12 December 2020

Initial 17beta-estradiol dose for treating vasomotor symptoms

1 reference

12 December 2020

A randomised comparison of the effects of oral versus transdermal 17beta-oestradiol, each combined with sequential oral norethisterone acetate, on serum lipoprotein levels

1 reference

12 December 2020

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

1 reference

12 December 2020

Dose-response evaluation of cyclic estrogen/gestagen in postmenopausal women: placebo-controlled trial of its gynecologic and metabolic actions.

1 reference

12 December 2020

HT or HRT, that is the question?

1 reference

12 December 2020

Double-blind and prolonged constant quinestrol therapy in the menopausal patient

1 reference

12 December 2020

Continuous low-dose oestrogen and progestogen hormone replacement therapy: a randomised trial.

1 reference

12 December 2020

Hormone therapy in women in the menopause transition. Randomised, double-blind, placebo-controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity, and the endometrium.

1 reference

12 December 2020

Two-year prospective, randomized trial comparing an innovative twice-a-week progestin regimen with a continuous combined regimen as postmenopausal hormone therapy

1 reference

12 December 2020

Rationale, design, and conduct of the PEPI Trial. Postmenopausal Estrogen/Progestin Interventions

1 reference

12 December 2020

[Postmenopausal hormone substitution and its effects on the climacteric syndrome, body weight and blood pressure]

1 reference

12 December 2020

Effect of oral medroxyprogesterone acetate on menopausal symptoms in patients with endometrial carcinoma

1 reference

12 December 2020

Efficacy and safety of a constant-estrogen, pulsed-progestin regimen in hormone replacement therapy

1 reference

12 December 2020

[Sequence therapy with estradiol valerate-norgestrel at menopause. A double-blind investigation]

1 reference

12 December 2020

Evaluation of an estrogen, androgen, estrogen-androgen combination, and a placebo in the treatment of the menopause

1 reference

12 December 2020

17Beta-estradiol delivered by three different matrix patches 50 microg/day: a three way cross-over study in 21 postmenopausal women

1 reference

12 December 2020

Climacteric symptoms after oral and percutaneous hormone replacement therapy

1 reference

12 December 2020

Oral menopausal therapy using 17- micronized estradiol. A preliminary study of effectiveness, tolerance and patient preference

1 reference

12 December 2020

[Double-blind method of the effect of menopause symptoms, lipid profile, and endometrial thickness of continuous therapy with estradiol valerate and medroxyprogesterone acetate]

1 reference

12 December 2020

Cardiovascular risk factors and combined estrogen-progestin replacement therapy: a placebo-controlled study with nomegestrol acetate and estradiol

1 reference

12 December 2020

Quality of life during sequential hormone replacement therapy -- a placebo-controlled study.

1 reference

12 December 2020

Efficacy of continuous sequential transdermal estradiol and norethindrone acetate in relieving vasomotor symptoms associated with menopause

1 reference

12 December 2020

Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women

1 reference

12 December 2020

A clinical trial of piperazine oestrone sulphate ('Harmogen') in the treatment of menopausal symptoms

1 reference

12 December 2020

Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices

1 reference

12 December 2020

The use of medroxyprogesterone acetate for relief of climacteric symptoms

1 reference

12 December 2020

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

1 reference

12 December 2020

Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution

1 reference

12 December 2020

An evaluation of clinical response to piperazine oestrone sulphate ('Harmogen') in menopause patients

1 reference

12 December 2020

Efficacy and tolerance of Menorest compared to Premarin in the treatment of postmenopausal women. A randomised, multicentre, double-blind, double-dummy study

1 reference

12 December 2020

Effect of cyclic estrone sulfate treatment on lipid profiles of postmenopausal women with elevated cholesterol levels

1 reference

12 December 2020

A double-blind, randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled, crossover study on the effect of oral oestradiol on acute menopausal symptoms

1 reference

12 December 2020

Double-blind, cross-over study comparing chlordiazepoxide, conjugated estrogens, combined chlordiazepoxide and conjugated estrogens, and placebo in treatment of the menopause

1 reference

12 December 2020

A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. Effects on bone mineral density, symptoms and lipid profiles.

1 reference

12 December 2020

A prospective one-year study of estrogen and progestin in postmenopausal women: effects on clinical symptoms and lipoprotein lipids.

1 reference

12 December 2020

Hormone therapy in postmenopausal women and risk of endometrial hyperplasia

1 reference

12 December 2020

The role of oestrogen replacement in the climacteric syndrome

1 reference

12 December 2020

Vitamin E and climacteric syndrome; failure of effective control as measured by menopausal index

1 reference

12 December 2020

Biological Effects of Various Doses of Conjugated Equine Estrogens in Postmenopausal Women*

1 reference

12 December 2020

Efficacy and acceptability of intranasal 17 beta-oestradiol for menopausal symptoms: randomised dose-response study. Aerodiol Study Group

1 reference

12 December 2020

Estrogen improves psychological function in asymptomatic postmenopausal women

1 reference

12 December 2020

Effect of oestriol succinate on serum lipids

1 reference

12 December 2020

Vaginal bleeding in postmenopausal women taking low-dose norethindrone acetate and ethinyl estradiol combinations. The FemHRT Study Investigators

1 reference

12 December 2020

Clinical experience with a low-dose combination of estradiol valerate and levonorgestrel. Double-blind comparative study between SH D 386 F and Cyclabil. Effects on symptoms, lipids and endometrial condition

1 reference

12 December 2020

Oral Complaints Related to Climacteric Symptoms in Oöphorectomized Women

1 reference

12 December 2020

Replacement estrogen therapy for menopausal vasomotor flushes. Comparison of quinestrol and conjugated estrogens

1 reference

12 December 2020

The true clincal features of postmenopause and oöphorectomy, and their response to oestrogen therapy

1 reference

12 December 2020

Continuous combined hormone replacement therapy compared with tibolone

1 reference

12 December 2020

Double blind study on the effect of estrogen on sleep, anxiety and depression in perimenopausal women: preliminary results

1 reference

12 December 2020

Oestrogen therapy and the menopausal syndrome

1 reference

12 December 2020

A prospective, controlled trial of six forms of hormone replacement therapy given to postmenopausal women

1 reference

12 December 2020